Cellebrite DI Statistics
Total Valuation
Cellebrite DI has a market cap or net worth of $2.66 billion. The enterprise value is $2.09 billion.
| Market Cap | 2.66B |
| Enterprise Value | 2.09B |
Important Dates
The last earnings date was Thursday, November 12, 2026, before market open.
| Earnings Date | Nov 12, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Cellebrite DI has 250.79 million shares outstanding. The number of shares has increased by 2.99% in one year.
| Current Share Class | 250.79M |
| Shares Outstanding | 250.79M |
| Shares Change (YoY) | +2.99% |
| Shares Change (QoQ) | +0.62% |
| Owned by Insiders (%) | 1.74% |
| Owned by Institutions (%) | 32.52% |
| Float | 99.14M |
Valuation Ratios
The trailing PE ratio is 42.46 and the forward PE ratio is 16.39. Cellebrite DI's PEG ratio is 0.80.
| PE Ratio | 42.46 |
| Forward PE | 16.39 |
| PS Ratio | 5.19 |
| Forward PS | 4.59 |
| PB Ratio | 4.79 |
| P/TBV Ratio | 8.16 |
| P/FCF Ratio | 16.80 |
| P/OCF Ratio | 15.42 |
| PEG Ratio | 0.80 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 23.87, with an EV/FCF ratio of 13.36.
| EV / Earnings | 34.29 |
| EV / Sales | 4.13 |
| EV / EBITDA | 23.87 |
| EV / EBIT | 34.81 |
| EV / FCF | 13.36 |
Financial Position
The company has a current ratio of 1.66, with a Debt / Equity ratio of 0.04.
| Current Ratio | 1.66 |
| Quick Ratio | 1.58 |
| Debt / Equity | 0.04 |
| Debt / EBITDA | 0.23 |
| Debt / FCF | 0.14 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 12.70% and return on invested capital (ROIC) is 42.26%.
| Return on Equity (ROE) | 12.70% |
| Return on Assets (ROA) | 4.19% |
| Return on Invested Capital (ROIC) | 42.26% |
| Return on Capital Employed (ROCE) | 9.47% |
| Weighted Average Cost of Capital (WACC) | 9.71% |
| Revenue Per Employee | $418,118 |
| Profits Per Employee | $50,360 |
| Employee Count | 1,285 |
| Asset Turnover | 0.56 |
| Inventory Turnover | 11.80 |
Taxes
In the past 12 months, Cellebrite DI has paid $17.61 million in taxes.
| Income Tax | 17.61M |
| Effective Tax Rate | 21.26% |
Stock Price Statistics
The stock price has decreased by -42.36% in the last 52 weeks. The beta is 1.01, so Cellebrite DI's price volatility has been similar to the market average.
| Beta (5Y) | 1.01 |
| 52-Week Price Change | -42.36% |
| 50-Day Moving Average | 11.58 |
| 200-Day Moving Average | 13.16 |
| Relative Strength Index (RSI) | 36.76 |
| Average Volume (20 Days) | 2,148,186 |
Short Selling Information
The latest short interest is 5.64 million, so 2.25% of the outstanding shares have been sold short.
| Short Interest | 5.64M |
| Short Previous Month | 7.22M |
| Short % of Shares Out | 2.25% |
| Short % of Float | 5.69% |
| Short Ratio (days to cover) | 3.34 |
Income Statement
In the last 12 months, Cellebrite DI had revenue of $537.28 million and earned $64.71 million in profits. Earnings per share was $0.25.
| Revenue | 537.28M |
| Gross Profit | 441.99M |
| Operating Income | 63.75M |
| Pretax Income | 82.83M |
| Net Income | 64.71M |
| EBITDA | 92.95M |
| EBIT | 63.75M |
| Earnings Per Share (EPS) | $0.25 |
Balance Sheet
The company has $593.28 million in cash and investments and $23.35 million in debt, with a net cash position of $569.93 million or $2.27 per share.
| Cash & Investments | 593.28M |
| Total Debt | 23.35M |
| Net Cash | 569.93M |
| Net Cash Per Share | $2.27 |
| Equity (Book Value) | 579.31M |
| Book Value Per Share | 2.32 |
| Working Capital | 262.96M |
Cash Flow
In the last 12 months, operating cash flow was $180.87 million and capital expenditures -$14.85 million, giving a free cash flow of $166.02 million.
| Operating Cash Flow | 180.87M |
| Capital Expenditures | -14.85M |
| Depreciation & Amortization | 29.20M |
| Net Borrowing | n/a |
| Free Cash Flow | 166.02M |
| FCF Per Share | $0.66 |
Margins
Gross margin is 82.26%, with operating and profit margins of 11.87% and 12.14%.
| Gross Margin | 82.26% |
| Operating Margin | 11.87% |
| Pretax Margin | 15.42% |
| Profit Margin | 12.14% |
| EBITDA Margin | 17.30% |
| EBIT Margin | 11.87% |
| FCF Margin | 30.90% |
Dividends & Yields
Cellebrite DI does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -2.99% |
| Shareholder Yield | -2.99% |
| Earnings Yield | 2.36% |
| FCF Yield | 5.95% |
Analyst Forecast
The average price target for Cellebrite DI is $15.43, which is 45.43% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $15.43 |
| Price Target Difference | 45.43% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 8 |
| Revenue Growth Forecast (3Y) | 15.03% |
| EPS Growth Forecast (3Y) | 16.71% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |
| Graham Formula Value | |
| Graham Formula Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Cellebrite DI has an Altman Z-Score of 5.46 and a Piotroski F-Score of 4.
| Altman Z-Score | 5.46 |
| Piotroski F-Score | 4 |